brain cancer epidemiology forecast insight

DelveInsight’s ‘Brain Cancer - Epidemiology Forecast–2034’ report delivers an in-depth understanding of the disease, historical and forecasted Brain Cancer epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Brain Cancer Understanding

A brain tumor, known as an intracranial tumor, central nervous system (CNS) tumors represent a group of diseases that have in common the abnormal development of mass lesions in the brain, spinal cord or its coverings. A brain tumor can be classified into two main groups, i.e. primary and metastatic. A primary brain tumor is often described as “low grade” or “high grade.” A low-grade tumor generally grows slowly, but it can turn into a high-grade tumor, whereas a high-grade tumor is more likely to grow faster. Secondary brain tumors, also called brain metastases, are much more common than primary tumors in adults. The most common types of primary tumors in adults are meningiomas and astrocytomas, such as glioblastomas. In children, the most common types of brain tumors include medulloblastomas, low-grade astrocytomas (pilocytic), ependymomas, craniopharyngiomas, and brainstem gliomas. All types of brain tumors produce symptoms that vary depending on the part of the brain involved. These symptoms may include headaches, seizures, problems with vision, vomiting and mental changes. Even though the exact cause of most brain tumors is unknown, some uncommon risk factors include exposure to chemicals, radiation, and family history of brain tumors.

Brain Cancer Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by by Total Incidence of Primary Brain Tumors, Grade-specific Incidence of Brain Tumors, Type-specific Incidence of Brain Tumors, Gender-specific Incidence of Brain Tumors, and Age-specific Incidence of Brain Tumors in the 7MM market covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan from 2021 to 2034.

Brain Cancer Detailed Epidemiology Segmentation

• The total incident population of Primary Brain Tumors in the seven major markets was estimated to be 60,246 in 2020. In case of Primary Brain Tumors patients in the United States, the incident cases were 23,056 in 2020.
• The total incident population of Primary Brain Tumors in the 7MM is expected to increase at a CAGR of 0.88% during the forecast period 2025-2034.
• Brain Tumors can be divided into, Low-grade (I and II) and High-grade (III and IV) tumors. In the United States, these cases were 6,917 and 16,139, respectively, in 2020.
• In the United States, the incidence of Brain Tumors was 13,534 in males and 9,522 in females, in 2020.
• There are many types of Brain Tumors; however, the types that are considered in this report include Pilocytic Astrocytoma, Diffuse Astrocytoma, Anaplastic Astrocytoma, Oligodendrogliomas, Glioblastoma Multiforme (GBM), Diffuse midline glioma (Earlier called as DIPG), and others, which represented 1,383, 3,458, 1,844, 1,614, 11,989, 853, and 1,914 cases, respectively, in the United States, in 2020.
• In the United States, the highest incidence of Brain Tumors was in the age-group 40–64 years with 10,144 cases, followed by the age-group ≥65 years with 8,992 cases in 2020. The lowest incidence of Brain Tumors was reported in the age-group 0–39 years with 3,919 cases in 2020.
• In the EU5 countries, the incident population of Primary Brain Tumors was maximum in Italy with 7,320 cases, followed by the Germany with 7,173 cases in 2020. While, the United Kingdom accounted for the lowest incident population of the indication with 4,433 cases in 2020.
• As per Delvelnsight’s analysis, Japan had 8,132 incident cases of Primary Brain Tumors in 2020.

Scope of the Report

• The report covers the descriptive overview of Brain Cancer, explaining its causes, signs and symptoms, pathophysiology.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan.
• The report assesses the disease risk and burden and highlights the unmet needs of Brain Cancer.
• The report provides the segmentation of the disease epidemiology for the 7MM by Total Incidence of Primary Brain Tumors, Grade-specific Incidence of Brain Tumors, Type-specific Incidence of Brain Tumors, Gender-specific Incidence of Brain Tumors, and Age-specific Incidence of Brain Tumors.

Report Highlights

• Ten Year Forecast of Brain Cancer
• 7MM Coverage
• Total Incident Population of Brain Cancer
• Delvelnsight has analysed incident population of Primary Brain Tumors in the 7MM which suggests that the cases of Primary Brain Tumors will increase during the forecast period of 2025-2034.
• In addition, gender-specific incidence of Brain Tumors was assessed as well. As per the analysis, Brain Tumors is slightly more incident in males than in females.
• The scope of the report also encompasses another major segment, i.e., grade-specific incidence Brain Cancer, wherein the number of patients suffering from Low-grade (I and II) and High-grade (III and IV) tumors was calculated.
• Age-specific data of Brain Tumors suggests that incidence of Brain Tumors in the US, was highest in the age group of 40–64 years, followed by ≥65 years and 0–39 years.
• There are many types of Brain Tumors; however, the types that are considered in this report include Pilocytic Astrocytoma, Diffuse Astrocytoma, Anaplastic Astrocytoma, Oligodendrogliomas, Glioblastoma Multiforme (GBM), Diffuse midline glioma (Earlier called as DIPG), and others.

Analyst Comments

• Through several literature studies it can be deduced that certain high-grade gliomas such as GBM and DIPG are quite rare. These are classified by their location and appearance when examined under a microscope. Additionally, GBM is more frequently observed in the patients as compared to Anaplastic Astrocytoma.
• The Central Brain Tumor Registry of the United States (CBTRUS) and the GLOBOCAN has been considered by DelveInsight to capture the number of incident cases of the indication and to forecast the epidemiology model of brain tumors.

Key Questions Answered

• What is the disease risk, burden and unmet needs of Brain Cancer?
• What is the historical Brain Cancer patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?
• What would be the forecasted patient pool of Brain Cancer at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Brain Cancer?
• Out of the above-mentioned countries, which country would have the highest incident population of Brain Cancer during the forecast period (2025-2034)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2025-2034)?

Reasons to buy

The Brain Cancer report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the 7MM Brain Cancer market.
• Quantify patient share distribution in the 7MM for Brain Cancer.
• The Brain Cancer epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The Brain Cancer epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the eleven-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population